Next Article in Journal
Neutrophil to Lymphocyte Ratio as a Biomarker for the Prediction of Cancer Outcomes and Immune-Related Adverse Events in a CTLA-4-Treated Population
Previous Article in Journal
Comment on Gentile et al. Superior Survival and Lower Recurrence Outcomes with Breast-Conserving Surgery Compared to Mastectomy Following Neoadjuvant Therapy in 607 Breast Cancer Patients. Cancers 2025, 17, 766
 
 
Reply
Peer-Review Record

Reply to Tjalma, W.A. Comment on “Gentile et al. Superior Survival and Lower Recurrence Outcomes with Breast-Conserving Surgery Compared to Mastectomy Following Neoadjuvant Therapy in 607 Breast Cancer Patients. Cancers 2025, 17, 766”

Cancers 2025, 17(12), 2009; https://doi.org/10.3390/cancers17122009
by Damiano Gentile 1,2,*, Jacopo Canzian 2,3, Erika Barbieri 1, Simone Di Maria Grimaldi 1, Rita De Sanctis 2,3 and Corrado Tinterri 1,2
Reviewer 1: Anonymous
Cancers 2025, 17(12), 2009; https://doi.org/10.3390/cancers17122009
Submission received: 30 May 2025 / Accepted: 13 June 2025 / Published: 17 June 2025
(This article belongs to the Section Cancer Therapy)

Round 1

Reviewer 1 Report

Comments and Suggestions for Authors

Thank you for the answer to the comment.

Back to TopTop